Harishchandra Sambhaji Jadhav

Title: Harishchandra Sambhaji Jadhav: Innovator in HIV Integrase Inhibitors

Introduction

Harishchandra Sambhaji Jadhav is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV integrase inhibitors. With a total of 2 patents to his name, Jadhav's work is crucial in advancing treatments for HIV.

Latest Patents

Jadhav's latest patents include a process for the preparation of intermediates used for the synthesis of HIV integrase inhibitors. This process is essential for creating compounds such as Bictegravir, Dolutegravir, and Cabotegravir, along with their pharmaceutically acceptable salts. Another significant patent he holds is for the preparation of HIV integrase inhibitors, which provides a compound of formula (XVII) with specific structural characteristics and a detailed process for its preparation.

Career Highlights

Harishchandra Sambhaji Jadhav is currently employed at Lupin, Inc., a prominent pharmaceutical company. His work at Lupin has allowed him to focus on innovative solutions for complex health challenges, particularly in the area of HIV treatment.

Collaborations

Some of Jadhav's notable coworkers include Dhananjai Shrivastava and Girij Pal Singh. Their collaboration has likely contributed to the successful development of new pharmaceutical processes and products.

Conclusion

Harishchandra Sambhaji Jadhav's contributions to the field of HIV integrase inhibitors highlight his role as an important inventor in the pharmaceutical industry. His innovative processes and collaborations continue to impact the development of effective treatments for HIV.